Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of climatic environment on immunological features of rheumatoid arthritis. | Sci Rep | 2023 | 36693893 | PubTator, text mining | PubMed |
| Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses. | Viruses | 2023 | 36680271 | PubTator, text mining | PubMed |
| T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients' Outcomes. | J Clin Med | 2023 | 36675642 | PubTator, text mining | PubMed |
| Effects of Bacillus subtilis Natto Strains on Antiviral Responses in Resiquimod-Stimulated Human M1-Phenotype Macrophages. | Foods | 2023 | 36673407 | PubTator, text mining | PubMed |
| A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients. | Proc Natl Acad Sci U S A | 2023 | 36669118 | PubTator, text mining | PubMed |
| Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load. | J Virol | 2023 | 36656015 | PubTator, text mining | PubMed |
| Rejection markers in kidney transplantation: do new technologies help children? | Pediatr Nephrol | 2023 | 36648536 | PubTator, text mining | PubMed |
| Targeted mechanical forces enhance the effects of tumor immunotherapy by regulating immune cells in the tumor microenvironment. | Cancer Biol Med | 2023 | 36647779 | PubTator, text mining | PubMed |
| Identification of seven hypoxia-related genes signature and risk score models for predicting prognosis for ovarian cancer. | Funct Integr Genomics | 2023 | 36642729 | PubTator, text mining | PubMed |
| A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. | BMC Cancer | 2023 | 36639648 | PubTator, text mining | PubMed |
| Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes. | BMC Cancer | 2023 | 36639629 | PubTator, text mining | PubMed |
| NK/T-cell lymphoma with rash and peripheral neuropathy as the first manifestation: a case report and literature review. | Diagn Pathol | 2023 | 36627681 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma. | Cancer Control | 2023 | 36625357 | PubTator, text mining | PubMed |
| Transcriptomic analysis of the innate immune response to in vitro transfection of plasmid DNA. | Mol Ther Nucleic Acids | 2023 | 36618265 | PubTator, text mining | PubMed |
| HBV genotype-dependent association of HLA variants with the serodecline of HBsAg in chronic hepatitis B patients. | Sci Rep | 2023 | 36611047 | PubTator, text mining | PubMed |
| A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective? | Inflammopharmacology | 2023 | 36609716 | PubTator, text mining | PubMed |
| Role of Traditional Chinese Medicine Syndrome Type, Gut Microbiome, and Host Immunity in Predicting Early and Advanced Stage Colorectal Cancer. | Integr Cancer Ther | 2023 | 36604798 | PubTator, text mining | PubMed |
| Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology. | Semin Immunopathol | 2023 | 36598557 | PubTator, text mining | PubMed |
| Clinical profile, etiology, and outcome of hemophagocytic lymphohistiocytosis associated with histiocytic necrotizing lymphadenitis. | World J Pediatr | 2023 | 36595187 | PubTator, text mining | PubMed |
| Innovation and renovation: FEBS Open Bio in 2023. | FEBS Open Bio | 2023 | 36594366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=34